Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000252923 | SCV000305221 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000252923 | SCV000515047 | likely benign | not specified | 2016-09-29 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV000252923 | SCV001158517 | likely benign | not specified | 2019-06-21 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001797606 | SCV002039477 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002504931 | SCV002806317 | likely benign | Lymphangiomyomatosis; Isolated focal cortical dysplasia type II; Tuberous sclerosis 2 | 2021-10-07 | criteria provided, single submitter | clinical testing | |
Tuberous sclerosis database |
RCV000043056 | SCV000066855 | not provided | Tuberous sclerosis syndrome | no assertion provided | curation |